DOH grants UAE IND for NeOnc's lead candidate NEO100
NeOnc Technologies received UAE IND approval for its lead candidate NEO100 across multiple dosing protocols. This authorization complements recent UAE clearance for NEO212 and precedes the imminent Phase 2a data readout in July.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day